It’s utterly simple. Stroke is a leading cause of death and long-term disability in the US, with heightened risk for low-income and marginalized groups. Outside of genetics, reducing these numbers ...

More than 795,000 people in the U.S. have a stroke each year, which is a leading cause of serious long-term disability. Many of the leading risk factors for stroke are modifiable, making prevention ...

The American Stroke Association just released new stroke prevention guidelines. They include considering GLP-1 receptor agonists. Doctors applaud the new guidance. More than 795,000 people in the U.S.

Lifestyle interventions, such as following a Mediterranean diet, can help lower the risk of stroke, new prevention guidelines advise. Image credit: Mariela Naplatanova/Stocksy. Stroke prevention is a ...

(WXYZ) — In today’s Health Alert, new stroke prevention guidelines have been released for the first time in a decade, focusing on the nation’s fourth leading ...

Asundexian significantly reduced the risk of recurrent stroke vs placebo when added to antiplatelet therapy. Topline results were announced from a phase 3 trial evaluating asundexian, an ...

Stroke is a leading cause of death and disability worldwide, with staggering statistics that demand urgent attention. Every year, approximately 12.2 million new strokes are diagnosed globally, and one ...

In 2018, Meritus Medical Center was treating an average of 600 stroke patients per year. Since then, the number has increased to more than 1,000 per year, said Jennifer Smith, B.S.N., R.N., stroke ...

AUGUSTA, Ga. (WJBF)-May is Stroke Awareness month. A time dedicated to raising awareness about stroke prevention, recognition, and treatment. And this week, Piedmont Augusta is hosting a community ...

OpEd: Just small investments in lifesaving training and practices could lessen Kentucky deaths from heart attacks and strokes.

Erin Adelekun was 38 when she had a stroke, just nine days after giving birth to her daughter in 2020. It all started with a headache, which had been about a 2 on a scale of 1 to 10 when she was ...

Factor XIa inhibitor milvexian did not provide meaningful secondary prevention over dual antiplatelet therapy for stroke survivors, the phase II trial AXIOMATIC-SSP found. In patients with recent ...